DIalysis Symptom COntrol-Pruritus Outcome Trial (DISCO-POT): A Multicenter Randomized Blinded Placebo Controlled Crossover Trial. (PubMed, Kidney Med) - Oct 18, 2026 - "Underpowered for secondary outcomes and to detect carryover effects, conservative nabilone dosing, short duration and a limited sample. We were unable to detect if nabilone had any effects on uremic pruritus compared with placebo."
Journal • Dermatology • Pruritus • Renal Disease
|
|
David Collister; Gwen Herrington; Kathy Cherepak; Lucy Delgado; Michael Walsh; Navdeep Tangri; Rachel Girimonte; Rocio Ayala Romero; Shun Fu Lee; Thomas Ferguson
|